[Therapy of obstructive respiratory tract diseases. I: Beta 2-sympathomimetic drugs and anticholinergic agents (m-cholinergic receptor blockers)].
作者信息
Ukena D, Schlimmer P, Sybrecht G W
出版信息
Med Klin (Munich). 1989 Jun 15;84(6):294-302.
PMID:2569161
Abstract
摘要
相似文献
1
[Therapy of obstructive respiratory tract diseases. I: Beta 2-sympathomimetic drugs and anticholinergic agents (m-cholinergic receptor blockers)].
Med Klin (Munich). 1989 Jun 15;84(6):294-302.
2
3
Use of beta 2-adrenergic drugs in obstructive respiratory tract diseases of childhood.β2-肾上腺素能药物在儿童阻塞性呼吸道疾病中的应用。
Ther Hung. 1990;38(3):117-24.
4
Controversies in pulmonary medicine. Patients with COPD should be started initially on anticholinergic bronchodilators.肺部医学中的争议。慢性阻塞性肺疾病患者最初应使用抗胆碱能支气管扩张剂进行治疗。
Am Rev Respir Dis. 1988 Oct;138(4):1074-5.
5
[Recommendations for a graduated system of long-term drug therapy of obstructive respiratory tract diseases].
Dtsch Med Wochenschr. 1984 Mar 9;109(10):392-5.
6
Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment.慢性抗胆碱能治疗对气道毒蕈碱胆碱能受体亚型的调节作用。
Mol Pharmacol. 1995 Mar;47(3):485-90.
7
[Recommendations for a stepwise plan of long-term drug therapy in obstructive airway diseases].[阻塞性气道疾病长期药物治疗分步计划的建议]
Dtsch Med Wochenschr. 1988 Oct 14;113(41):1609-12.
8
[Bronchodilator treatment of chronic obstructive bronchopneumopathies].[慢性阻塞性支气管肺炎的支气管扩张剂治疗]
Rev Mal Respir. 1993;10(2):79-85.
9
[Treatment of obstructive respiratory tract diseases. Principles of rational pharmacotherapy].[阻塞性呼吸道疾病的治疗。合理药物治疗原则]
Fortschr Med. 1989 Jul 20;107(21):453-4.
10
[Beta-2 agonists in the therapy of obstructive airway diseases].[β-2 激动剂在阻塞性气道疾病治疗中的应用]
Praxis (Bern 1994). 1996 Sep 17;85(38):1159-61.
Zotero 插件